Search results
Results from the WOW.Com Content Network
The following table lists the largest biotechnology and pharmaceutical companies ranked by revenue in billion USD. The change column indicates the company's relative position in this list compared to its relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
The following table lists the largest biotechnology and pharmaceutical companies ranked by market capitalization in billion US dollars. The change column indicates the company's relative position in this list compared to their relative position in the preceding year; i.e., an increase would be moving closer to rank 1 and vice versa.
S&P 500 constituent Air Products and Chemicals Inc. (NYSE: APD) is spinning off Versum Materials. Air Products and Chemicals will remain in the S&P 500 post spin-off. [238] September 30, 2016: DO: Diamond Offshore Drilling: PLCM: Polycom: Siris Capital Group acquired Polycom. Coty, Inc. replaces Diamond Offshore in the S&P 500 index. [239 ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Wave Life Sciences wasn’t one of them. The 10 stocks that made ...
These business groups provide fluid management products and systems to customers in biotechnology, pharmaceutical, transfusion medicine, energy, electronics, municipal and industrial water purification, aerospace, transportation and broad industrial markets. The company was founded by David B. Pall in 1946 as Micro Metallic Corporation. [12]
Galena Biopharma, Inc. (originally RXi Pharmaceuticals) was a publicly traded pharmaceutical company based in San Ramon, California. The company was founded in Worcester , Massachusetts . In 2011, it moved to Oregon, [ 1 ] [ 2 ] and in 2015 moved to San Ramon, California . [ 3 ]
For premium support please call: 800-290-4726 more ways to reach us
It operates with software as a service (SaaS) company in the life-science industry. [3] Veeva Systems Inc. went public on the New York Stock Exchange in October 2013. [4] [5] As of May 5, 2022, it has a market capitalization of US$27.5 billion. [6] On February 1, 2021, Veeva became a public benefit corporation. This made it the first publicly ...